EHA Library - The official digital education library of European Hematology Association (EHA)

Epigenetic inhibitors in hematological malignancies
EHA Library. Huntly B. 06/15/18; 219125 Topic: 2B Acute myeloid leukemia (AML) and leukemias of ambiguous lineage
Dr. Brian Huntly
Dr. Brian Huntly
Contributions
Learning Objectives
• describe current and emerging epigenetic therapies for haematological malignancies, particularly AML,
• link these inhibitors to mechanisms of action and potential sensitive genotypes, and
• identify timing and possible partners for combined use in AML.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies